publication venue for
- Susceptibility‐weighted imaging to evaluate normal and abnormal vertebrae in fetuses: A preliminary study. 42:1398-1408. 2022
- A novel “video‐game” simulator for training fetoscopic laser coagulation of anastomoses in twin‐to‐twin transfusion syndrome. 41:1589-1592. 2021
- Uterine artery and umbilical vein blood flow are unaffected by moderate habitual physical activity during pregnancy. 39:976-985. 2019
- QF‐PCR rapid aneuploidy screen and aCGH analysis of cell free fetal (cff) DNA in supernatant of compromised amniotic fluids (AF). 34:970-976. 2014
- Prenatal counseling for congenital anomaly tests: parental preferences and perceptions of midwife performance. 33:341-353. 2013
- Second and first trimester estimation of risk for Down syndrome: implementation and performance in the SAFER study. 30:459-466. 2010
- Prenatal diagnosis of Smith‐Lemli‐Opitz syndrome (SLOS) by DHCR7 mutation analysis. 27:638-640. 2007
- Identifying Smith–Lemli–Opitz syndrome in conjunction with prenatal screening for Down syndrome. 26:842-849. 2006
- The effect of fetal gender on the false-positive rate of Down syndrome by maternal serum screening. 25:1258-1261. 2005
- The influence of risk estimates obtained from maternal serum screening on amniocentesis rates. 25:1253-1257. 2005
- Simple non-invasive prenatal detection of Hb Bart's disease by analysis of fetal erythrocytes in maternal blood. 25:123-128. 2005
- Low first‐trimester pregnancy‐associated plasma protein‐A and Cornelia de Lange syndrome. 23:864-864. 2003
- A further case of confined placental mosaicism for trisomy 2 associated with adverse pregnancy outcome. 23:564-565. 2003
- Frequency and clinical consequences of extremely high maternal serum PAPP‐A levels. 23:385-388. 2003
- First trimester screening with free β‐hCG, PAPP‐A and nuchal translucency in pregnancies conceived with assisted reproduction. 22:718-721. 2002
- Recurrent fetomaternal transfusion in two consecutive pregnancies. 21:791-793. 2001
- Embryonic and fetal globins are expressed in adult erythroid progenitor cells and in erythroid cell cultures. 21:529-539. 2001
- First trimester biochemical screening for Down syndrome: free beta hCG versus intact hCG. 20:785-789. 2000
- Preferences of women facing a prenatal diagnostic choice: long‐term outcomes matter most. 19:711-716. 1999
- Technical factors in early amniocentesis predict adverse outcome. Results of the Canadian early (EA) versus mid-trimester (MA) amniocentesis trial. 19:732-738. 1999
- RhD status of a fetus at risk for haemolytic disease with a discrepant maternal DNA-based RhD genotype. 19:424-427. 1999
- Clinical follow-up of high mid-trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnancies. 19:219-223. 1999
- A report of recurrent anencephaly with trisomy 2p23-2pter: additional evidence for the involvement of 2p24 in neural tube development and evaluation of the role for cytogenetic analysis. 17:665-669. 1997
- Identification of a novel β0 ‐ thalassaemia mutation in a greek family and subsequent prenatal diagnosis. 14:929-932. 1994
- Prenatal diagnosis of fragile X syndrome: Management of the male fetus with a premutation. 14:469-474. 1994
- Annex 2: Detailed obstetrical procedures and results. 12:411-422. 1992
- Annex 3: Fetal and neonatal losses. 12:423-432. 1992
- Annex 4: Surviving births. 12:433-438. 1992
- First‐trimester diagnosis of Hunter syndrome (MPS II). 12:72-73. 1992